No Detail Found!

Pediatric onset neuronal ceroid lipofuscinoses: Unraveling clinical and genetic specifications

Author(s)
Saher Gul Ahdi University of Child Health Sciences, The Children’s Hospital, Lahore, Pakistan.
Javeria Raza Alvi Department of Pediatric Neurology, University of Child Health Sciences & The Children's Hospital,Lahore,Pakistan
Azeem Ashfaq University of Child Health Sciences, The Children’s Hospital, Lahore, Pakistan.
Tipu Sultan University of Child Health Sciences, The Children’s Hospital, Lahore, Pakistan.
Abstract
Objective: To unravel the clinical and genetic specifications of Neuronal ceroid lipofuscinosis (NCL). Methods: This is a retrospective cross-sectional study conducted in the Department of Pediatric Neurology Children Hospital and University of Child Health Sciences, Lahore, Pakistan from March 2017 to March 2022. The primary outcome was to measure genotype-phenotype correlation by segregation of phenotypes according to genotype. The secondary outcomes included a correlation between genotype and distribution of age(s) of onset. Results: One hundred fifty three patients clinically diagnosed with NCL underwent genetic testing and pathologic mutation was identified in 32.7% of patients. About 59.6% were male and 37.2% had an afected sibling. The median age was 5.46±1.95 years at the onset of the first symptom i.e., myoclonic seizures in 68%, and motor dificulty in 24%. Other features found were global developmental delay (56%), hypotonia (23%), visual impairment (80%), ataxia (22%), and disc pallor (56%). The most common type was CLN6 (Ceroid lipofuscinosis neuronal) (42%), CLN2 (16%) followed by CLN7 (12%). When 50 patients with recognized mutations were compared with 103 patients with no mutation, family history (p=0.049), early visual loss (p=0.016), hypotonia (p=0.001), white matter signals (p=0.026) and pan-atrophy(p=0.047) was statistically significant in the genetically confirmed NCL. Multiple pairwise comparisons indicated that the estimated age of onset for the CLN1 and CLN2 mutation group was significantly lower than other genotypes including CLN6 (p 0.012), CLN10 (p 0.007) and CLN12 (p 0.007). Conclusion: Following a detailed review of NCL symptomatology, a clinically-oriented approach should be used for a rapid diagnosis with confirmation by targeted molecular testing for future genetic counseling.
Publication Details
Page(s) 1638-1643
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 8, Year: 2024

Request the full text from PASTIC

Keywords
Genotype, Optic atrophy, phenotype, Neuronal ceroid lipofuscinoses, Myoclonic Jerks
References
Nickel M .2022 .Schulz A. Natural History Studies in NCL and Their Expanding Role in Drug Development: Experiences From CLN2 Disease and Relevance for Clinical Trials. Front Neurol, 10 : 785841.
Mole SE,Cotman SL .2015 .Genetics of the neuronal ceroid lipofuscinoses (Batten disease). Biochim Biophys Acta, 05 : 2237-2241.
Laren DM,Mathavarajah S,Huber RJ .2019 .Recent Insights into NCL Protein Function Using the Model Organism Dictyostelium discoideum. Cells, 10(2) : .
Azad B,Efthymiou S,Sultan T,Scala M,Alvi JR,Neuray C .2020 .Novel likely disease-causing CLN5 variants identified in Pakistani patients with neuronal ceroid lipofuscinosis. J Neurol Sci, 10 : 116826.
Butz ES,Chandrachud U,Mole SE,Cotman SL .2019 .9):165571. Biochim Biophys Acta Mol Basis Dis, 10 : .
Kamate M,Reddy N,Detroja M,Hattiholi V .2021 .Neuronal Ceroid Lipofuscinoses in Children. Ann Indian Acad Neurol, 24(2) : 192-197.
Nelvagal HR,Lange J,Takahashi K,Tarczyluk-Wells MA,Cooper JD .2019 .9):165570. Biochim Biophys Acta Mol Basis Dis, 10 : .
Sinha S,Satishchandra P,Santosh V,Gayatri N,Shankar SK .2004 .Neuronal ceroid lipofuscinosis: a clinicopathological study. Seizure, 1311(03) : 00163-8.
Gowda VK,Vegda H,Sugumar K,Narayanappa G,Srinivasan VM,Santhoshkumar R .2020 .Neuronal Ceroid Lipofuscinosis: Clinical and Laboratory Profile in Children from Tertiary Care Centre in South India. J Pediatr Genet, 10(4) : 1715575-273.
Puga AC,Jardim LB,Chimelli L,Souza CF,Clivati M. .2000 .Neuronal ceroid lipofuscinoses: a clinical and morphological study of 17 patients from southern Brazil. , 58 : 597-606.
Haltia M,Goebel HH .2012 .The neuronal ceroid-lipofuscinoses: a historical introduction. Biochim Biophys Acta, 08 : 1795-1800.
Jilani A,Matviychuk D,Blaser S,Dyack S,Mathieu J,Prasad AN .2019 .High diagnostic yield of direct Sanger sequencing in the diagnosis of neuronal ceroid lipofuscinoses. JIMD Rep, 10(1) : 20-30.
Simonati A,Williams RE .2022 .Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview. Front Neurol, 10 : 811686.
Kozina AA,Okuneva EG,Baryshnikova NV,Kondakova OB,Nikolaeva EA,Fedoniuk ID .2020 .Neuronal ceroid lipofuscinosis in the Russian population: Two novel mutations and the prevalence of heterozygous carriers. Mol Genet Genomic Med, 10(7) : .
Gao Z,Xie H,Jiang Q,Wu N,Chen X,Chen Q .2018 .Identification of two novel null variants in CLN8 by targeted next-generation sequencing: first report of a Chinese patient with neuronal ceroid lipofuscinosis due to CLN8 variants. BMC Med Genet, 19(1) : 21.
Guerreiro R,Bras JT,Vieira M,Warrier V,Agrawal S,Stewart H,Anderson G,Mole SE .2013 .CLN6 disease caused by the same mutation originating in Pakistan has varying pathology. Europ J Paediatr Neurol, 17(6) : 657-660.
Sher M,Farooq M,Abdullah U,Ali Z,Faryal S,Zakaria M .2019 .A novel in-frame mutation in CLN3 leads to Juvenile neuronal ceroid lipofuscinosis in a large Pakistani family. Int J Neurosci, 10(9) : 890-895.
Ebrahimi-Fakhari D,Hildebrandt C,Davis PE,Rodan LH,Anselm I,Bodamer O. .2018 .The Spectrum of Movement Disorders in ChildhoodOnset Lysosomal Storage Diseases. Mov Disord Clin Pract, 10(2) : 12573-155.
Autti T,Joensuu R .2007 .Decreased T2 signal in the thalami may be a sign of lysosomal storage disease. Neuroradiol, 49(07) : 571-578.
di Ronza A,Bajaj L,Sharma J,Sanagasetti D,Lotfi P,Adamski CJ .2018 .CLN8 is an endoplasmic reticulum cargo receptor that regulates lysosome biogenesis. Nat Cell Biol, 10(12) : 1370-1377.
Biswas A,Krishnan P,Amirabadi A,Blaser S,Mercimek-Andrews S,Shroff M. Expanding .2020 .the Neuroimaging Phenotype of Neuronal Ceroid Lipofuscinoses. Am J Neuroradiol, 10(10) : 1930-1936.
Radke J,Stenzel W,Goebel HH .2015 .. Human NCL Neuropathology. Biochim Biophys Acta, 05 : 2262-2266.
0

Citations

0

Downloads

79

Views